Literature DB >> 28870072

Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery.

Qing Yao1,2, Zhi Dai1, Jong Hoon Choi1, Dongin Kim1, Lin Zhu1.   

Abstract

In this study, we described an "all-in-one" polymer-lipid conjugate (PEG2k-ppTAT-PEG1k-PE) that could self-assemble to matrix metalloproteinase 2 (MMP2)-sensitive multifunctional micelles. The assembled micelles had several key features, including a protective long chain poly(ethylene glycol) (PEG2k) (the outer shell), an MMP2-sensitive peptide linker (pp) (the tumor-targeting middle layer), a trans-activating transcriptional activator (TAT) peptide (the cell-penetrating middle layer), and a stable PEG1k-PE micelle for drug loading (the inner core). In the absence of MMP2, the PEG2k-ppTAT-PEG1k-PE micelles were intact and showed low bioactivity due to the surface-anchored PEG2k, whereas in the presence of MMP2, the pp was cleaved, resulting in the PEG2k deshielding and exposure of the previously hidden TAT for enhanced intracellular drug delivery. Even if completely cleaved by MMP2, the remaining PEG1k-PE micelles were stable and the micelles' particle size and drug release were not significantly influenced. The paclitaxel (PTX)-loaded PEG2k-ppTAT-PEG1k-PE micelles showed significant MMP2-dependent cellular uptake, tumor penetration, and anticancer activity in various cancer cells and three-dimensional multicellular spheroids. Because of the enhanced intracellular drug accumulation, these multifunctional micelles were able to sensitize the drug-resistant cancer cells and their spheroids to PTX treatments. Furthermore, in vivo tumor uptake and retention data indicated that the PEG2k-ppTAT-PEG1k-PE micelles could dramatically increase the residence time of their payloads in the tumor.

Entities:  

Keywords:  cell-penetrating peptide; matrix metalloproteinase; multifunctional nanocarrier; polymeric micelles; stimuli-responsive

Mesh:

Substances:

Year:  2017        PMID: 28870072     DOI: 10.1021/acsami.7b09511

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  14 in total

1.  Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles.

Authors:  Qing Yao; Yin Liu; Longfa Kou; Ying Tu; Xing Tang; Lin Zhu
Journal:  Nanomedicine       Date:  2019-04-17       Impact factor: 5.307

Review 2.  Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system.

Authors:  Sharath Kumar Hari; Ankita Gauba; Neeraj Shrivastava; Ravi Mani Tripathi; Sudhir Kumar Jain; Akhilesh Kumar Pandey
Journal:  Drug Deliv Transl Res       Date:  2022-06-21       Impact factor: 4.617

Review 3.  Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models.

Authors:  Sayoni Maitra Roy; Vrinda Garg; Sourav Barman; Chitrita Ghosh; Amit Ranjan Maity; Surya K Ghosh
Journal:  Front Bioeng Biotechnol       Date:  2021-12-01

Review 4.  Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors.

Authors:  Bernadette Xin Jie Tune; Maw Shin Sim; Chit Laa Poh; Rhanye Mac Guad; Choy Ker Woon; Iswar Hazarika; Anju Das; Subash C B Gopinath; Mariappan Rajan; Mahendran Sekar; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria; Kalaivani Batumalaie; Yuan Seng Wu
Journal:  J Oncol       Date:  2022-05-09       Impact factor: 4.501

Review 5.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

6.  Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.

Authors:  Xi He; Kaimin Cai; Yu Zhang; Yifei Lu; Qin Guo; Yujie Zhang; Lisha Liu; Chunhui Ruan; Qinjun Chen; Xinli Chen; Chao Li; Tao Sun; Jianjun Cheng; Chen Jiang
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-09       Impact factor: 9.229

7.  The Impact of Tyrosine Iodination on the Aggregation and Cleavage Kinetics of MMP-9-Responsive Peptide Sequences.

Authors:  Douglas S MacPherson; Scott A McPhee; Brian M Zeglis; Rein V Ulijn
Journal:  ACS Biomater Sci Eng       Date:  2022-01-20

Review 8.  Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.

Authors:  Longfa Kou; Yangzom D Bhutia; Qing Yao; Zhonggui He; Jin Sun; Vadivel Ganapathy
Journal:  Front Pharmacol       Date:  2018-01-26       Impact factor: 5.810

9.  Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy.

Authors:  Xi He; Jinxiao Zhang; Chao Li; Yu Zhang; Yifei Lu; Yujie Zhang; Lisha Liu; Chunhui Ruan; Qinjun Chen; Xinli Chen; Qin Guo; Tao Sun; Jianjun Cheng; Chen Jiang
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

10.  A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy.

Authors:  Shiwei Niu; Gareth R Williams; Jianrong Wu; Junzi Wu; Xuejing Zhang; Xia Chen; Shude Li; Jianlin Jiao; Li-Min Zhu
Journal:  J Nanobiotechnology       Date:  2019-09-10       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.